Dividends & Buybacks ·
Glucotrack completes 1-for-2 reverse stock split effective Oct 26, 2026
GCTKGlucotrack, Inc.
Glucotrack filed a Certificate of Amendment to effect a one-for-two (1-for-2) reverse stock split of its common stock, which became effective on October 23, 2026. The transaction was approved by stockholders in August and reduced outstanding shares from approximately 2.4 million to roughly 1.18 million without changing par value or authorized share count. Options and warrants were proportionally adjusted. This filing also includes pro forma financial statements reflecting the July merger with Lokahi Therapeutics, which added $25.4 million in intangible assets and $15.6 million in goodwill, alongside approximately $7.95 million in bridge financing proceeds. Glucotrack operates in the medical technology sector, focusing on diabetes management solutions.